Zdrowie i gospodarka · 13/02/2015

Identifying Potential Biomarkers for Qualification and Describing Contexts of Use To Address Areas Important to Drug Development; Request for Comments

The US Food and Drug Administration (FDA) is requesting comments to identify potential biomarkers for drug development and describe contexts of use, with a focus on advancing human therapeutics. The agency encourages input from interested groups and individuals on specific medical areas where novel biomarkers can be identified.